+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 65Years
MALE
Healthy Volunteers
ID07459270

Study of Psychiatric Symptoms in Male Adults With Methamphetamine-Induced Psychotic Disorder With and Without Cannabis Use

Led by Elazığ Mental Health and Diseases Hospital · Updated on 2026-09-10

90

Participants Needed

2

Research Sites

10 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying psychiatric symptom severity in adult males diagnosed with methamphetamine-induced psychotic disorder MP, comparing those with and without lifetime cannabis use LCU. The study aims to understand whether LCU affects symptom progression and to identify environmental, individual, and family factors linked to psychiatric symptoms in these participants. This prospective cohort study includes hospitalized males at a mental health hospital who meet DSM-5-TR criteria for MP. Participants are divided into two groups based on cannabis use history one with MP plus LCU, defined as using cannabis at least three times in the past 30 days or more than 40 times in the past year, and the other with MP without any lifetime cannabis use. No treatments are assigned by the study. Participants complete baseline sociodemographic and clinical forms and are then assessed weekly for eight weeks during inpatient follow-up using standardized psychiatric and addiction assessment scales. During the eight-week hospitalization, psychiatric symptoms and clinical characteristics are evaluated weekly with tools including the Insight Assessment Scale, Addiction Profile Index Clinical-Practitioner Form, Positive and Negative Syndrome Scale, Global Assessment Scale, and Pittsburgh Sleep Quality Index. Researchers track symptom changes and factors influencing severity, analyzing data after follow-up for scientific publication. The total participation time is eight weeks, with weekly assessments throughout hospitalization.

CONDITIONS

Brief Title

Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Use

Research Team

M

Mehmet Hamdi ÖRÜM, MD, Assoc. Prof., Psychiatrist

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here